FindTrial
Sign In

ChAdOx1 biEBOV

BIOLOGICAL2 trials

Sponsors

University of Oxford

Conditions

Ebola

Phase 1

A Study of a New Vaccine Against Two Types of Ebola
CompletedNCT05079750
University of OxfordEbola
Start: 2021-11-11End: 2023-03-21Updated: 2025-04-04
A Study in Tanzania of a New Vaccine Against Two Types of Ebola
NCT05301504
University of OxfordEbola
Start: 2022-03-30End: 2023-12-31Target: 76Updated: 2023-02-08

Related Papers

Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial.
2025-02-053 citations